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Background-—Multiple percutaneous coronary interventions (PCIs) are considered determinant of poor outcome in patients
undergoing coronary artery bypass grafting (CABG), but scarce data exist to substantiate this.
Methods and Results-—Patients who underwent CABG without history of prior PCI or with PCI performed >30 days before surgery
were selected for the present analysis from the prospective, multicenter E-CABG (European Multicenter Study on Coronary Artery
Bypass Grafting) registry. Out of 6563 patients with data on preoperative SYNTAX (Synergy between PCI With Taxus and Cardiac
Surgery) score, 1181 patients (18.0%) had undergone PCI >30 days before CABG. Of these, 11.6% underwent a single PCI, 4.4% 2
PCIs, and 2.1% ≥3 PCIs. PCI of a single main coronary vessel was performed in 11.3%, of 2 main vessels in 4.9%, and of 3 main
vessels in 1.6% of patients. Multivariable analysis showed that differences in early mortality and other outcomes were not
significantly different in the study cohorts. The adjusted hospital/30-day mortality rate was 1.8% in patients without history of prior
PCI, 1.9% in those with a history of 1 PCI, 1.4% after 2 PCIs, and 2.5% after ≥3 PCIs (adjusted P=0.8). The adjusted hospital/30-day
mortality rate was 2.0% in those who had undergone PCI of 1 main coronary vessel, 1.3% after PCI of 2 main vessels, and 3.1% after
PCI of 3 main coronary vessels (adjusted P=0.6).
Conclusions-—Multiple prior PCIs are not associated with increased risk of early adverse events in patients undergoing isolated
CABG. The present results are conditional to survival after PCI and should not be viewed as a support for a policy of multiple PCI as
opposed to earlier CABG.
Clinical Trial Registration-—URL: http://www.Clinicaltrials.gov. Unique identifier: NCT02319083. ( J Am Heart Assoc. 2018;7:
e010089. DOI: 10.1161/JAHA.118.010089.)
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C urrently, an increasing number of patients undergoingcoronary artery bypass grafting (CABG) have previously
been treated with percutaneous coronary intervention (PCI). A
recent study from the Society of Thoracic Surgeons 2018 Adult
Cardiac Surgery Database showed that 28.9% of patients who
underwent isolated CABG had a prior PCI, which was performed
before the index hospitalization in 25% of patients.1 This figure
has increased as compared with the previous decade, when the
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ORIGINAL RESEARCH
overall prevalence of prior PCI in the Society of Thoracic
Surgeons 2008 Adult Cardiac Surgery Database was 21.3%.2
Analysis of patients who had surgery in 2015 from the E-CABG
registry (EuropeanMulticenter Study onCoronary Artery Bypass
Grafting), showed that 21.9% of patients had a history of prior
PCI and 18.8% underwent isolated CABG >30 days after PCI.3
This study showed that prior PCI was not associated with worse
early outcome.3 However, the accompanying meta-analysis
including 71 366 patients from 8 studies showed a trend
toward higher in-hospital/30-day mortality (adjusted odds ratio
[OR], 1.30; 95% confidence interval [CI], 0.99–1.70) in patients
with prior PCI. However, some of the available studies were
potentially biased by the lack of adequate adjustment for
important confounders. Multiple prior PCI procedures and
multiple treated vessels could hypothetically be associatedwith
worse outcome, but scarce data exist to substantiate this.4 We
sought to investigate this issue in patientswho had surgery from
2015 to 2017 from the E-CABG registry.
Methods
The E-CABG registry is a prospective, multicenter study that
enrolled patients undergoing isolated CABG at 16 European
centers of cardiac surgery in Finland, France, Italy, Germany,
Sweden, and the United Kingdom. The study is registered in
Clinicaltrials.gov (Identifier: NCT02319083). The detailed pro-
tocol and definition criteria have been previously published.5
This study was approved by the Institutional Review Board of
the participating centers. Informed consent was obtained
when required by the Institutional Review Board; otherwise, it
was waived. Because of restrictions in sharing patient
information, the data, analytic methods, and study materials
will not be made available to other researchers for purposes of
reproducing the results or replicating the procedure.
This registry included 7352 consecutive patients who
underwent isolated CABG at the participating hospitals from
January 2015 to May 2017. Patients who underwent any other
concomitant procedure on the heart valves, ascending aorta,
and ventricular wall were not included in this registry. Data
were collected prospectively and underwent checking of its
quality. For the purpose of this study, only patients with
complete data on the timing and number of PCIs and vessels
treated and on the SYNTAX (Synergy Between PCI With Taxus
and Cardiac Surgery) score were included in this analysis.
Patients who underwent PCI ≤30 days from CABG were
excluded from this study because indication for surgical
revascularization might be related to acute complication of
PCI or severe ischemia not successfully treated by PCI.
Outcomes
Hospital/30-day death was the primary outcome of this
study. Secondary outcomes were 1-year all-cause mortality,
length of stay in the intensive care unit, stroke, postoperative
use of intra-aortic balloon pump and/or extracorporeal
membrane oxygenation, acute kidney injury, renal replace-
ment therapy, and E-CABG bleeding grades 2 to 3. Postop-
erative acute kidney injury was defined according to the
KDIGO (Kidney Disease: Improving Global Outcomes) criteria.6
E-CABG bleeding grades 2 to 3 was defined as bleeding
requiring reoperation or transfusion of >4 units of red blood
cells.5 The definition criteria of the other outcomes were
previously published.5
Statistical Analysis
Statistical analyses were performed using SPSS version 24.0
(IBM Corporation, New York, USA) and Stata version 14.2
(StataCorp LLC, TX, USA) statistical software. The Mantel-
Haenszel, Kruskal-Wallis, and Kaplan-Meier tests were used
for univariate analysis of baseline and operative data as well
as outcomes of the study cohorts. Logistic, linear, and Cox
proportional hazard regression analyses were performed to
evaluate the impact on the outcomes of increasing numbers
of prior PCIs as well as main coronary vessels treated by PCI.
Regression models assessing the outcomes in patients with
increasing number of PCIs were adjusted by the following
baseline risk factors, which significantly differed between
subgroups of patients: age, body mass index, dialysis, anemia,
pause of P2Y12 receptor inhibitors <5 days before surgery,
diabetes mellitus, prior cardiac surgery, urgency of the
procedure, SYNTAX score, off-pump surgery, and number of
distal anastomoses. Similarly, regression models assessing
the outcomes in patients with an increasing number of main
coronary vessels treated by PCI were adjusted by the
following baseline risk factors, which significantly differed
between subgroups of patients with increasing number of
prior PCIs: age, female sex, dialysis, pause of P2Y12 receptor
Clinical Perspective
What Is New?
• Multiple prior percutaneous coronary interventions do not
increasetheriskofearlyadverseeventsafter isolatedcoronary
artery bypass grafting.
What Are the Clinical Implications?
• Although the present results are conditional to survival after
percutaneous coronary intervention, a policy of multiple
percutaneous coronary interventions does not compromise
the early outcome of an eventual isolated coronary artery
bypass grafting.
DOI: 10.1161/JAHA.118.010089 Journal of the American Heart Association 2















inhibitors <5 days before surgery, diabetes mellitus, prior
cardiac surgery, urgency of the procedure, SYNTAX score, off-
pump surgery, and number of distal anastomoses. The
observed number of events was divided by the risk-adjusted
expected number of events to produce observed-to-expected
ratios. The risk-adjusted expected number of events was
estimated by logistic regression with backward modality. Early
adjusted mortality rates for each subgroup was estimated by
multiplying the observed-to-expected ratio by the mean
outcome rate. All tests were 2-sided, and P<0.05 was set
for statistical significance.
Results
The flow chart of patient selection of this study is depicted in
the Figure. Of 7352 patients operated from January 2015 to
May 2017 and included in the E-CABG registry, 1540 (20.9%)
had a prior PCI, and 1524 patients (99.0%) had complete data
on the date of last PCI and the number of PCIs performed. Two-
hundred thirty-five patients (15.4% of patients with prior PCI)
underwent CABGwithin 30 days of prior PCI and were excluded
from the analysis. These patients had a higher risk of in-
hospital/30-day death than those with prior PCI performed
>30 days from surgery (3.8% versus 1.8%; unadjusted
P=0.044), a difference that was not statistically significant
when adjusted for EuroSCORE (European System for Cardiac
Operative Risk Evaluation) II (OR, 1.553; 95% CI, 0.658–3.666).
Among 5812 patients without prior PCI, 5382 patients had
data on preoperative SYNTAX score (92.6%). Among 1309
patients who underwent CABG >30 days after PCI, 1181
patients (90.2%) had complete data on the timing and
number of PCIs as well as on preoperative SYNTAX score
(Figure).
When adjusted for baseline covariates listed in Table 1
along with surgical technique, bilateral internal mammary
artery grafting and number of distal anastomoses, patients
undergoing CABG after any prior PCI did not have an
increased risk of hospital/30-day (1.7% versus 1.9%; adjusted
P=0.8), intermediate mortality (1-year mortality, 3.6% versus
3.5%; adjusted P=0.9), stroke (1.0% versus 1.2%; adjusted
P=1.0), length of intensive care unit stay (mean 2.83.6
versus 2.94.5 days; adjusted P=1.0), postoperative inser-
tion of intra-aortic balloon pump and/or extracorporeal
membrane oxygenation (3.3% versus 4.9%; adjusted P=0.1),
KDIGO acute kidney injury (21.3% versus 22.8%; adjusted
P=0.2) and dialysis (1.8% versus 1.8%; adjusted P=0.8), but
they showed a trend toward increased risk of severe/massive
bleeding (7.8% versus 6.4%; adjusted P=0.06; OR 1.284, 95%
CI, 0.989–1.667).
Number of Prior PCIs and Outcome After CABG
A single PCI was performed in 759 patients (11.6%), 2 PCIs
in 287 patients (4.4%), and ≥3 PCIs in 135 patients (2.1%)
(Table 1). The operative risk was higher, particularly in
Figure. Flow chart of patient selection for the present analysis. CABG indicates coronary artery bypass
grafting; PCI, percutaneous coronary intervention; SYNTAX, Synergy Between PCI With Taxus and Cardiac
Surgery.
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patients who underwent ≥3 PCIs. The crude hospital/30-day
mortality rates in these study cohorts were 1.9%, 1.6%, 1.4%,
and 3.0%, respectively (Table 2). Early mortality and other
outcomes were not significantly different in the study
cohorts either in univariate and multivariable analyses
(Table 2).
Table 1. Baseline Characteristics and Operative Data According to the Number of Prior PCIs
Covariates No Prior PCI (5382 Pts) 1 Prior PCI (759 Pts) 2 Prior PCIs (287 Pts) ≥3 Prior PCIs (135 Pts) P Value
Baseline risk factors
Age, y 67.89.3 66.29.6 66.79.2 67.78.8 <0.0001
Female 915 (17.0) 109 (14.4) 41 (14.3) 20 (14.8) 0.058
Body mass index 27.54.1 27.54.2 28.14.3 26.74.0 0.016
eGFR, mL/min per 1.73 m2 7620 7620 7422 7324 0.627
Dialysis 54 (1.0) 11 (1.4) 4 (1.4) 6 (4.4) 0.002
Anemia 1202 (22.4) 151 (19.9) 75 (26.1) 49 (36.3) <0.0001
Diabetes mellitus 1632 (30.3) 246 (32.4) 109 (38.0) 62 (45.9) <0.0001
Acute coronary syndrome 2630 (48.9) 344 (45.3) 127 (44.3) 74 (54.8) 0.420
Recent STEMI 293 (5.4) 57 (7.5) 13 (4.5) 6 (4.4) 0.782
Prior stroke/TIA 319 (5.9) 47 (6.2) 23 (8.0) 7 (5.2) 0.457
Atrial fibrillation 442 (8.2) 46 (6.1) 33 (11.5) 19 (14.1) 0.067
Pulmonary disease 529 (9.8) 75 (9.9) 30 (10.5) 13 (9.6) 0.863
Extracardiac arteriopathy 1207 (22.4) 178 (23.5) 77 (26.8) 36 (26.7) 0.046
Prior cardiac surgery 20 (0.4) 6 (0.8) 5 (1.7) 4 (3.0) <0.0001
Left ventricular ejection fraction ≤50% 1517 (28.2) 206 (27.1) 86 (30.0) 45 (33.6) 0.327
Critical preoperative state 359 (6.7) 34 (4.5) 19 (6.6) 6 (4.4) 0.101
Urgency of the procedure 0.001
Urgent 2253 (41.9) 251 (33.1) 102 (35.5) 57 (42.5)
Emergency 259 (4.8) 17 (2.2) 11 (3.8) 9 (6.7)
P2Y12 receptor inhibitors pause <5 d 663 (12.3) 150 (19.8) 66 (23.0) 38 (28.1) <0.0001
Indication for surgery
In-stent restenosis  218 (28.8) 130 (45.3) 92 (68.7) <0.0001
Stent thrombosis  44 (5.8) 23 (8.0) 14 (10.4) <0.0001
Coronary artery disease progression  567 (74.8) 226 (78.7) 107 (79.3) <0.0001
Left main coronary artery PCI  33 (4.3) 12 (4.2) 19 (14.1) <0.0001
Any drug-eluting stent  384 (51.8) 180 (63.2) 107 (81.7) <0.0001
Delay from last PCI, y  6.26.2 5.64.9 3.64.2 0.001
SYNTAX score 2912 2612 2712 2812 <0.0001
EuroSCORE II, % 2.84.1 2.33.7 2.94.1 3.76.1 <0.0001
Operative data
No. of distal anastomoses 2.80.9 2.50.9 2.50.9 2.40.9 <0.0001
Cardiopulmonary bypass time, min 8636 7931 8434 8334 0.670
Aortic clamping time, min 5826 5523 5627 5828 0.067
Off-pump surgery 1024 (19.0) 181 (23.8) 75 (26.1) 43 (31.9) <0.0001
Bilateral internal mammary artery grafts 2022 (37.6) 319 (42.0) 103 (35.9) 40 (29.6) 0.609
Continuous variables are reported as the meanstandard deviation. Categorical variables are reported as counts and percentages. Anemia is defined as baseline hemoglobin concentration
<12.0 g/L in women and <13.0 g/L in men. Clinical variables are according to the EuroSCORE II definition criteria. eGFR indicates estimated glomerular filtration rate according to the
Modification of Diet in Renal Disease equation; EuroSCORE, European System for Cardiac Operative Risk Evaluation; PCI, percutaneous coronary intervention; STEMI, ST-elevation
myocardial infarction; SYNTAX, Synergy Between PCI With Taxus and Cardiac Surgery; TIA, transient ischemic attack.
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Number of Coronary Vessels Previously Treated
by PCI and Outcome After CABG
For the purpose of this study, the coronary system was divided
into 3 main coronary vessels: the left anterior descending
coronary artery, the circumflex coronary artery, and the right
coronary artery. PCI was considered multiple when performed
in >1 of these main coronary vessels. For the sake of simplicity
and because of the small number of such cases (64 patients,
1.0%), PCI of the left main coronary artery was considered as a
procedure involving 2 main coronary vessels. PCI of a single
main coronary vessel was performed in 741 patients (11.3%), of
2 main vessels in 320 patients (4.9%), and of 3 main vessels in
106 patients (1.6%) (Table 3). The crude hospital/30-day
mortality rates in these study cohorts were 1.9%, 1.6%, 1.3%,
and 3.8%, respectively (Table 4). Despite an increased Euro-
SCORE II, particularly in patients who had undergone PCI of all 3
coronary vessels, differences in early mortality and other
outcomeswere not significantly different in the study cohorts in
univariate and multivariable analyses (Table 4).
Adjusted Rates of Hospital/30-Day Mortality
Logistic regression identified age (P<0.001), female sex
(P=0.001), urgency of the procedure (P<0.0001), the SYNTAX
score (P=0.003), left ventricular ejection fraction ≤50%
(P<0.0001), critical preoperative state (P=0.005), ST-elevation
myocardial infarction (P<0.0001), and estimated glomerular
filtration rate (P<0.0001) as independent predictors of
hospital/30-day mortality. When outcome was adjusted by
these independent risk factors, the adjusted hospital/30-day
mortality rate was 1.8% in patients without a history of prior
PCI, 1.9% in those who underwent 1 PCI, 1.4% after 2 PCIs,
and 2.5% after ≥3 PCIs (adjusted P=0.8). The adjusted
hospital/30-day mortality rate was 1.8% in patients without a
history of prior PCI, 2.0% in those who underwent PCI of 1
main coronary vessel, 1.3% after PCI of 2 main vessels, and
3.1% after PCI of 3 main vessels (adjusted P=0.6).
Outcomes in Patients With Recent Exposure to
P2Y12 Receptor Inhibitors
In view of the increased prevalence of exposure to potent
antiplatelets in patients with prior PCI (Tables 1 and 3), a
pause of P2Y12 receptor inhibitors less than 5 days before
surgery was included in all adjusted analyses of this study.
When adjusted for the number of prior PCIs and all risk
factors listed in the Statistical Analysis section, a pause of
P2Y12 receptor inhibitors <5 days before surgery was not
associated with increased risk of early death (P=0.5),












Hospital/30-d death 103 (1.9) 12 (1.6) 4 (1.4) 4 (3.0) 0.935
Adjusted risk estimates Reference 1.09, 0.59 to 2.03 0.75, 0.27 to 2.13 1.12, 0.38 to 3.30 0.933
1-y mortality, % 3.5 3.2 3.9 4.8 0.857
Adjusted risk estimates Reference 1.00, 0.66 to 1.52 0.92, 0.50 to 1.70 0.79, 0.34 to 1.77 0.937
Intensive care unit stay, d 2.94.5 2.73.7 3.03.2 3.03.8 0.309
Adjusted risk estimates Reference 0.02, 0.35 to 0.31 0.14, 0.38 to 0.65 0.09, 0.83 to 0.66 0.853
Stroke 62 (1.2) 7 (0.7) 4 (1.4) 1 (0.7) 0.769
Adjusted risk estimates Reference 0.95, 0.43 to 2.11 1.42, 0.51 to 3.99 0.64, 0.08 to 4.75 0.874
Postoperative IABP or ECMO 263 (4.9) 26 (3.4) 8 (2.8) 5 (3.7) 0.034
Adjusted risk estimates Reference 0.82, 0.53 to 1.26 0.60, 0.29 to 1.25 0.59, 0.22 to 1.54 0.314
KDIGO acute kidney injury* 1204 (22.8) 165 (22.1) 60 (21.3) 21 (16.4) 0.122
Adjusted risk estimates Reference 1.01, 0.83 to 1.22 0.85, 0.63 to 1.15 0.59, 0.36 to 0.97 0.143
Renal replacement therapy* 95 (1.8) 12 (1.6) 5 (1.8) 4 (3.1) 0.597
Adjusted risk estimates Reference 1.04, 0.56 to 1.94 0.95, 0.38 to 2.39 1.53, 0.53 to 4.41 0.884
E-CABG bleeding grades 2–3 344 (6.4) 60 (7.9) 18 (6.3) 14 (10.4) 0.080
Adjusted risk estimates Reference 1.42, 1.05 to 1.92 0.93, 0.55 to 1.55 1.17, 0.63 to 2.17 0.133
Continuous variables are reported as the meanstandard deviation. Categorical variables are reported as counts and percentages. Estimates are odds ratios and hazard rates with 95%
confidence interval (CI). ECMO indicates extracorporeal membrane oxygenation; E-CABG, European Multicenter Study on Coronary Artery Bypass Grafting; IABP, intra-aortic balloon pump;
KDIGO, Kidney Disease Improving Global Outcomes; PCI, percutaneous coronary intervention.
*Patients with chronic kidney disease class 5 excluded from the analysis.
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intermediate death (P=0.6), stroke (P=0.6), length of intensive
care unit stay (P=1.0), and postoperative insertion of intra-
aortic balloon pump and/or extracorporeal membrane
oxygenation (P=0.07). However, a pause of P2Y12 receptor
inhibitors <5 days before surgery was an independent
predictor of severe/massive bleeding (P<0.0001; OR, 1.933,




Prior PCI on 1 Main
Coronary Vessel (741 Pts)
Prior PCI on 2 Main
Coronary Vessels (320 Pts)
Prior PCI on 3 Main
Coronary Vessels (106 Pts) P Value
Baseline risk factors
Age, y 67.89.3 66.29.7 67.18.9 66.49.0 <0.0001
Female 915 (17.0) 114 (15.4) 40 (12.5) 16 (15.1) 0.035
Body mass index 27.54.1 27.54.2 28.04.4 27.04.3 0.185
eGFR, mL/min per 1.73 m2 7620 7720 7422 7323 0.248
Dialysis 54 (1.0) 9 (1.2) 7 (2.2) 4 (3.8) 0.003
Anemia 1202 (22.4) 156 (21.1) 85 (26.6) 32 (30.2) 0.064
Diabetes mellitus 1632 (30.3) 249 (33.6) 123 (38.4) 42 (39.6) <0.0001
Acute coronary syndrome 2630 (48.9) 341 (46.0) 141 (44.1) 57 (53.8) 0.264
Recent STEMI 293 (5.4) 55 (7.4) 13 (4.1) 7 (6.6) 0.573
Prior stroke/TIA 319 (5.9) 42 (5.7) 25 (7.8) 9 (8.5) 0.168
Atrial fibrillation 442 (8.2) 50 (6.7) 29 (9.1) 16 (15.1) 0.228
Pulmonary disease 529 (9.8) 72 (9.7) 35 (10.9) 8 (7.5) 0.943
Extracardiac arteriopathy 1207 (22.4) 172 (23.2) 91 (28.4) 23 (21.7) 0.092
Prior cardiac surgery 20 (0.4) 8 (1.1) 4 (1.3) 3 (2.8) <0.0001
Left ventricular ejection fraction ≤50% 1517 (28.2) 202 (27.3) 98 (30.6) 32 (30.5) 0.507
Critical preoperative state 359 (6.7) 34 (4.6) 17 (5.3) 7 (6.6) 0.119
Urgency of the procedure <0.0001
Urgent 2253 (41.9) 250 (33.7) 110 (34.4) 46 (43.8)
Emergency 259 (4.8) 19 (2.6) 12 (3.8) 5 (4.8)
P2Y12 receptor inhibitors pause <5 d 66.3 (12.3) 154 (20.8) 67 (20.9) 26 (24.5) <0.0001
Indication for surgery
In-stent restenosis  221 (29.8) 149 (46.9) 69 (65.1) <0.0001
Stent thrombosis  43 (5.8) 31 (9.7) 7 (6.6) <0.0001
Coronary artery disease progression  545 (73.5) 267 (83.7) 86 (81.1) <0.0001
Left main coronary artery PCI  10 (1.3) 20 (6.3) 33 (31.1) <0.0001
Any drug-eluting stent  378 (52.4) 206 (65.0) 86 (81.9) <0.0001
Delay from last PCI, y  5.96.0 5.75.3 3.74.3 0.003
SYNTAX score 2912 2611 2812 2713 <0.0001
EuroSCORE II, % 2.84.1 2.54.0 2.84.4 3.24.2 <0.0001
Operative data
No. of distal anastomoses 2.80.9 2.50.9 2.60.9 2.40.9 <0.0001
Cardiopulmonary bypass time, min 8636 7932 8231 8339 0.066
Aortic clamping time, minute 5826 5525 5624 5828 <0.0001
Off-pump surgery 1024 (19.0) 182 (24.6) 82 (25.6) 29 (27.4) <0.0001
Bilateral internal mammary artery grafts 2022 (37.6) 306 (41.3) 121 (37.8) 29 (27.4) 0.747
Continuous variables are reported as the meanstandard deviation. Categorical variables are reported as counts and percentages. Anemia is defined as baseline hemoglobin concentration
<12.0 g/L in women and <13.0 g/L in men. Clinical variables are according to the EuroSCORE II definition criteria. eGFR indicates estimated glomerular filtration rate according to the
Modification of Diet in Renal Disease equation; EuroSCORE, European System for Cardiac Operative Risk Evaluation; PCI, percutaneous coronary intervention; STEMI, ST-elevation
myocardial infarction; SYNTAX, Synergy Between PCI With Taxus and Cardiac Surgery; TIA, transient ischemic attack.
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95% CI, 1.524–2.452) and KDIGO acute kidney injury
(P=0.001; OR, 1.319, 95% CI, 1.116–1.559), and it showed
a trend toward increased risk of postoperative dialysis
(P=0.052; OR, 1.569, 95% CI, 0.998–2.428).
Discussion
The E-CABG registry is a prospective, multicenter study, which
was designed to specifically address the impact of prior PCI
on the outcome after CABG by collecting data on the timing,
type, and number of PCIs, along with the severity of coronary
artery disease quantified by the SYNTAX score. This analysis
showed that early outcomes of patients undergoing isolated
CABG are not jeopardized by multiple prior PCIs. Although we
decided to exclude patients undergoing CABG soon after PCI,
analysis of this larger series adjusted for EuroSCORE II also
showed that CABG performed soon after PCI can be
performed without increased risk of death. Overall, these
findings have important clinical implications, as CABG is
performed in a large number of patients with prior PCI7 and
seems to be a valid revascularization strategy even after
failure of multiple stents and/or progression of coronary
artery disease. Importantly, patients who had a history of ≥3
prior PCIs or in whom PCI was performed in all 3 main
coronary arteries had a significantly higher estimated oper-
ative risk compared with patients without a history of prior
PCI and to those with a history of 1 or 2 prior PCIs (Tables 1
and 3). Despite their incremental estimated operative risk, the
rates of adverse events in these patients was numerically
higher than those of the other study cohorts, but the
difference did not reach statistical significance (Tables 2
and 4).
Data on the prognostic impact of multiple PCIs are scant.
Thielmann et al8 showed that multiple prior PCIs increased
the risk of early mortality and major cardiac and cardiovas-
cular events in a single center series. The same authors
evaluated the impact of multiple prior PCIs in patients
undergoing CABG from a large multicenter series.4 The
authors demonstrated that ≥2 prior PCIs were associated with
significantly increased risk of in-hospital mortality (adjusted
OR, 2.02; 95% CI, 1.36–2.99) and major cardiac and
cardiovascular events (adjusted OR, 1.51; 95% CI, 1.17–
1.93) after CABG. Similar findings were observed in propen-
sity score matching analysis, even if the authors did not report
the characteristics of the matched populations. However, this
study most likely also included patients who underwent CABG
early after PCI, and this might introduce a bias related to the
characteristics of patients with early PCI failure. Importantly,
Table 4. Outcomes According to the Number of Main Coronary Vessels Treated by PCI
No Prior PCI
(5382 Pts)
Prior PCI on 1
Main Coronary
Vessel (741 Pts)
Prior PCI on 2
Main Coronary
Vessels (320 Pts)






Hospital/30-d death 103 (1.9) 12 (1.6) 4 (1.3) 4 (3.8) 0.989
Adjusted risk estimates Reference 1.10, 0.59 to 2.05 0.70, 0.25 to 2.00 1.94, 0.65 to 5.78 0.559
1-y mortality, % 3.5 2.7 4.9 6.1 0.284
Adjusted risk estimates Reference 0.81, 0.52 to 1.28 1.19, 0.70 to 2.02 1.38, 0.61 to 3.15 0.581
Intensive care unit stay, d 2.94.5 2.73.2 3.14.8 2.41.9 0.678
Adjusted risk estimates Reference 0.03, 0.37 to 0.31 0.26, 0.23 to 0.75 0.51, 1.35 to 0.33 0.984
Stroke 62 (1.2) 7 (0.9) 3 (0.9) 2 (1.9) 0.970
Adjusted risk estimates Reference 0.98, 0.44 to 2.16 0.89, 0.28 to 2.88 1.64, 0.38 to 7.05 0.919
Postoperative IABP or ECMO 263 (4.9) 23 (3.1) 10 (3.1) 5 (4.7) 0.057
Adjusted risk estimates Reference 0.75, 0.48 to 1.18 0.69, 0.36 to 1.34 0.86, 0.33 to 2.25 0.457
KDIGO acute kidney injury* 1204 (22.8) 158 (21.6) 68 (21.9) 15 (14.9) 0.113
Adjusted risk estimates Reference 0.97, 0.80 to 1.18 0.92, 0.70 to 1.22 0.57, 0.33 to 1.00 0.248
Renal replacement therapy* 95 (1.8) 10 (1.4) 6 (1.9) 4 (3.9) 0.504
Adjusted risk estimates Reference 0.88, 0.45 to 1.71 1.11, 0.47 to 2.58 2.34, 0.82 to 6.68 0.416
E-CABG bleeding grades 2 to 3 344 (6.4) 54 (7.3) 25 (7.8) 11 (10.4) 0.052
Adjusted risk estimates Reference 1.29, 0.94 to 1.76 1.28, 0.82 to 1.98 1.49, 0.73 to 2.86 0.243
Continuous variables are reported as the meanstandard deviation. Categorical variables are reported as counts and percentages. Estimates are odds ratios and hazard rates with their
related 95% confidence interval (CI). E-CABG indicates European Multicenter Study on Coronary Artery Bypass Grafting; ECMO, extracorporeal membrane oxygenation; IABP, intra-aortic
balloon pump; KDIGO, Kidney Disease Improving Global Outcomes; PCI, percutaneous coronary intervention.
*Patients with chronic kidney disease class 5 excluded from the analysis.
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patients were operated on from 2000 to 2005, and PCIs were
performed with previous generations’ stent technology and
secondary prevention strategy. Furthermore, that study was
retrospective and the outcome of patients was not adjusted
for the extent of coronary artery disease. Indeed, the present
study showed that SYNTAX score was an independent
predictor of hospital/30-day death and therefore is a
confounding factor in the analysis of the outcome of these
patients.
A few studies showed that multiple prior PCIs do not have
an impact on early mortality. Mannacio et al9 showed that
multiple PCI was not associated with increased risk of
hospital death, but it increased the risk of major cardiac and
cardiovascular events. However, the authors reported an
increased risk of 5-year mortality and 3-year cardiac mortality
in patients with multiple prior PCIs.9 In the study by Stevens
et al,10 30-day mortality after CABG was no different in
patients with 1 versus multiple PCIs (1.2% versus 0.9%;
P=0.8).
In this study, we observed that patients with an increasing
number of prior PCIs and branches treated had an increased
prevalence of pause of P2Y12 receptor inhibitors <5 days
before CABG, which did not affect the early and intermediate
survival, but significantly increased the risk of postoperative
acute kidney injury and severe bleeding. Indeed, a trend
toward increased risk of severe/massive bleeding was also
observed in patients with any prior PCI compared with those
without a history of PCI (7.8% versus 6.4%; adjusted P=0.06;
OR 1.284, 95% CI, 0.989–1.667). Such complications may in
turn unfavorably impact the late outcome of these patients.
The present study has several limitations. First, despite the
fact that this is a large multicenter study, it is not powered to
detect differences in the outcome of patients who previously
underwent >1 PCI or in whom PCI was performed in 2 or 3
main coronary arteries. Second, we do not have any
information on the length of stented vessels, which might
have an impact on the feasibility of surgical revascularization
as well as on the choice of grafts and site of anastomosis.
Third, these outcomes were adjusted for the SYNTAX score,
but most likely this angiographic score may not define to what
extent the side branches and collateral circulation was
affected by PCI. Fourth, these findings may not apply to
patients undergoing CABG combined with heart valve and/or
aortic procedures. In fact, exclusion of side branches and
collateral circulation during PCI may have clinical significance
in terms of myocardial protection in patients undergoing
combined surgical procedures and requiring prolonged aortic
cross-clamp time. Still, occlusion of side branches occurring
after PCI is often clinically silent and occluded branches can
be found patent at later angiography.11 Fifth, the short
follow-up of this series does not allow an analysis of the long-
term impact of multiple prior PCIs in these patients. Finally,
the present results are conditional to survival after PCI and
should not be viewed as a support for a policy of multiple PCIs
as opposed to earlier CABG.
In conclusion, this prospective, multicenter study specif-
ically addressed the impact of prior PCIs and showed that
having undergone multiple prior PCIs is not associated with
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